GluN3A knockout mouse: Alternative model for Alzheimer’s neurodegeneration
In the context of recent debate over the FDA’s approval of aducanumab, it’s refreshing to learn about a model of Alzheimer’s neurodegeneration that doesn’t start with the pathogenic proteins amyloid or Tau. A new paper in Alzheimer’s & Dementia from Emory neuroscientist Shan Ping Yu and colleagues focuses on an unusual member of the family…